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Survival and Functional Outcomes After Hip Fracture Among Nursing Home
Residents
Abstract
Importance
Little is known regarding outcomes after hip fracture among long-term nursing home residents.
Objective
To describe patterns and predictors of mortality and functional decline in activities of daily living (ADLs)
among nursing home residents after hip fracture.
Design, Setting, and Participants
Retrospective cohort study of 60 111 Medicare beneficiaries residing in nursing homes who were
hospitalized with hip fractures between July 1, 2005, and June 30, 2009.
Main Outcomes and Measures
Data sources included Medicare claims and the Nursing Home Minimum Data Set. Main outcomes
included death from any cause at 180 days after fracture and a composite outcome of death or new total
dependence in locomotion at the latest available assessment within 180 days. Additional analyses
described within-residents changes in function in 7 ADLs before and after fracture.
Results
Of 60 111 patients, 21 766 (36.2%) died by 180 days after fracture; among patients not totally dependent
in locomotion at baseline, 53.5% died or developed new total dependence within 180 days. Within
individual patients, function declined substantially after fracture across all ADL domains assessed. In
adjusted analyses, the greatest decreases in survival after fracture occurred with age older than 90 years
(vs ≤75 years: hazard ratio [HR], 2.17; 95% CI, 2.09-2.26 [P < .001]), nonoperative fracture management
(vs internal fixation: HR for death, 2.08; 95% CI, 2.01-2.15 [P < .001]), and advanced comorbidity (Charlson
score of ≥5 vs 0: HR, 1.66; 95% CI, 1.58-1.73 [P < .001]). The combined risk of death or new total
dependence in locomotion within 180 days was greatest among patients with very severe cognitive
impairment (vs intact cognition: relative risk [RR], 1.66; 95% CI, 1.56-1.77 [P < .001]), patients receiving
nonoperative management (vs internal fixation: RR, 1.48; 95% CI, 1.45-1.51 [P < .001]), and patients older
than 90 years (vs ≤75 years: RR, 1.42; 95% CI, 1.37-1.46 [P < .001]).
Conclusions and Relevance
Survival and functional outcomes are poor after hip fracture among nursing home residents, particularly
for patients receiving nonoperative management, the oldest old, and patients with multiple comorbidities
and advanced cognitive impairment. Care planning should incorporate appropriate prognostic information
related to outcomes in this population.
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IMPORTANCE Little is known regarding outcomes after hip fracture among long-term nursing
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Invited Commentary
page 1281
Supplemental content at
jamainternalmedicine.com

OBJECTIVE To describe patterns and predictors of mortality and functional decline in
activities of daily living (ADLs) among nursing home residents after hip fracture.
DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of 60 111 Medicare
beneficiaries residing in nursing homes who were hospitalized with hip fractures between
July 1, 2005, and June 30, 2009.
MAIN OUTCOMES AND MEASURES Data sources included Medicare claims and the Nursing
Home Minimum Data Set. Main outcomes included death from any cause at 180 days after
fracture and a composite outcome of death or new total dependence in locomotion at the
latest available assessment within 180 days. Additional analyses described within-residents
changes in function in 7 ADLs before and after fracture.
RESULTS Of 60 111 patients, 21 766 (36.2%) died by 180 days after fracture; among patients
not totally dependent in locomotion at baseline, 53.5% died or developed new total
dependence within 180 days. Within individual patients, function declined substantially after
fracture across all ADL domains assessed. In adjusted analyses, the greatest decreases in
survival after fracture occurred with age older than 90 years (vs ⱕ75 years: hazard ratio [HR],
2.17; 95% CI, 2.09-2.26 [P < .001]), nonoperative fracture management (vs internal fixation:
HR for death, 2.08; 95% CI, 2.01-2.15 [P < .001]), and advanced comorbidity (Charlson score
of ⱖ5 vs 0: HR, 1.66; 95% CI, 1.58-1.73 [P < .001]). The combined risk of death or new total
dependence in locomotion within 180 days was greatest among patients with very severe
cognitive impairment (vs intact cognition: relative risk [RR], 1.66; 95% CI, 1.56-1.77
[P < .001]), patients receiving nonoperative management (vs internal fixation: RR, 1.48; 95%
CI, 1.45-1.51 [P < .001]), and patients older than 90 years (vs ⱕ75 years: RR, 1.42; 95% CI,
1.37-1.46 [P < .001]).
CONCLUSIONS AND RELEVANCE Survival and functional outcomes are poor after hip fracture
among nursing home residents, particularly for patients receiving nonoperative
management, the oldest old, and patients with multiple comorbidities and advanced
cognitive impairment. Care planning should incorporate appropriate prognostic information
related to outcomes in this population.
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H

ip fractures (HFs) occur more than 300 000 times each
year among older US adults,1,2 resulting in substantial mortality3,4 and loss of functional independence.5,6
Residents of long-term nursing homes are twice as likely as
community-dwelling individuals to sustain a HF,7-9 and outcomes after fracture are worse among nursing home residents than among community dwellers.10-12 Nonetheless, past
cohort studies of HF have commonly excluded nursing home
residents,4,5,13-15 and studies that have focused on nursing home
residents with HFs have been limited by small sample
sizes,12,16,17 single-center designs,18-20 and lack of data on functional outcomes.17,18 As a result, little is currently known about
patterns and predictors of mortality and functional decline
among nursing home residents with HFs.
We undertook a retrospective cohort study to examine outcomes among all fee-for-service Medicare beneficiaries who
were hospitalized with an acute HF between July 1, 2005, and
June 30, 2009, and who were living in a nursing home prior to
fracture. Our study had 3 goals: first, we aimed to characterize patterns of survival and new total dependence in locomotion among nursing home residents at 6 months and a year after HF; second, we sought to describe within-residents changes
in functional dependence in 7 activities of daily living (ADLs)
before and after fracture; finally, we aimed to identify risk factors associated with survival after HF, along with a composite
outcome of death or new total dependence in locomotion
within 180 days after fracture.

Methods
Data Sources and Study Sample
This study was approved by the institutional review boards of
the Perelman School of Medicine and The Children’s Hospital
of Philadelphia. Our data set merged the following administrative and clinical data sources: (1) the 2005-2009 LongTerm Care Minimum Data Set (MDS), which contains standardized, validated clinical assessments completed by nurses
for all residents in Medicare- or Medicaid-certified US nursing homes at the time of admission and at specified intervals
thereafter21-24; (2) the 2005-2009 100% Medicare Provider
Analysis and Review (MedPAR) files, which include claims for
inpatient hospital care for all fee-for-service Medicare beneficiaries; and (3) the 2005-2009 Medicare Beneficiary Summary File, which records health maintenance organization
(HMO) enrollment and vital status information. Beneficiaries
were linked across files using an encrypted unique identifier.
To identify Medicare beneficiaries who were hospitalized with an acute HF and were residents in a long-term nursing home prior to hospitalization, we first identified all beneficiaries who had a hospital discharge record with a principal
or secondary discharge diagnosis code indicating an acute femoral neck, intertrochanteric, or subtrochanteric fracture (International Classification of Diseases, Ninth Revision, Clinical
Modification [ICD-9-CM] diagnosis codes 820.00-09, 820.0119, 820.21-2, 820.31-2, and 820.8-9) between July 1, 2005, and
June 30, 2009. To ensure that we included only acute admissions for HF, rather than readmissions, we considered the first
1274

recorded HF admission to be the index, and we excluded from
our sample any patient hospitalized for HF between July 1,
2005, and December 31, 2005, who had been hospitalized for
HF in the preceding 180 days.
We next identified patients who were residents in longterm nursing homes prior to fracture. As all Medicare- and Medicaid-certified nursing homes are required to complete MDS
assessments of residents at admission and at intervals no
greater than 92 days thereafter, we followed prior investigators in using the presence of 2 MDS assessments within
an appropriate interval as an indicator of nursing home
residence.25-27 Specifically, we selected all individuals with 2
or more routine quarterly assessments in the MDS or an MDS
admission assessment followed by a quarterly assessment in
the 184 days before the index hospitalization. We considered
MDS assessments conducted for changes in clinical status or
to correct errors in earlier assessments to be equivalent to quarterly assessments.

Independent Variables: Baseline Characteristics
and Acute Fracture Management
We collected data from MedPAR files on patient age, sex, and
race, which we coded as black, white, and other.28 As in previous work, we used ICD-9-CM diagnosis codes to create indicator variables for the anatomic location of the fracture (femoral neck, intertrochanteric, subtrochanteric, or multiple
locations).29 We used ICD-9-CM procedure codes (see eTable
1 in the Supplement) to identify receipt of surgical HF treatment via total hip arthroplasty, hemiarthroplasty, or internal
fixation during the index admission. We considered patients
without an ICD-9-CM code for any of the aforementioned treatments to have received nonoperative management. We used
validated algorithms to identify 16 Charlson comorbidities30
based on ICD-9-CM diagnosis codes for all hospitalizations in
the 180 days prior to the index admission and information on
chronic medical conditions recorded in the last MDS assessment prior to admission.30,31
We collected data from the MDS on self-performance in
ADLs using each individual’s last MDS quarterly assessment
prior to the index admission. Following past investigations that
have used MDS data to measure changes over time in ADL
function,25-27,32 we obtained information regarding baseline
self-performance in 7 ADLs: (1) locomotion on the nursing home
unit, (2) dressing, (3) personal hygiene, (4) using the toilet,
(5) transferring between surfaces, (6) getting in and out of bed,
and (7) eating. Detailed descriptions of these ADL domains appear in eTable 2 in the Supplement.
For each ADL domain, MDS assessors graded resident selfperformance as observed across all nursing shifts over a 7-day
period. Grading used a 5-point scale with the following categories: independent, supervision, limited assistance, extensive assistance, and total dependence. Within the MDS, independent in a given ADL indicated the ability to perform that
activity without help or oversight or requiring help or oversight only 1 or 2 times over 7 days; total dependence indicated the need for full staff performance of that activity for all
7 days. For this analysis, patients for whom a particular ADL
did not occur over 7 days were classified as being totally de-
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pendent in that domain. A detailed description of the MDS ADL
self-performance grading scale appears in eTable 3 in the
Supplement.
To obtain a measure of baseline cognitive status, we used
the MDS Cognitive Performance Scale (CPS).33 The CPS is a validated measure that grades cognition on a 7-point scale ranging from “intact” to “very severe impairment” based on MDS
items describing cognition over a 7-day period. Increasing CPS
values correlate highly with decreasing scores on the Folstein
Mini-Mental Status Examination.33,34 As with prefracture ADL
assessments, baseline CPS scores were obtained from the last
available MDS assessment prior to the index admission.

Outcome Variables
Our primary outcome was death from any cause within 180
days of hospital admission. In addition, we examined postfracture self-performance for each of the 7 ADLs as recorded
in the last available MDS assessment within 180 days after the
index admission. Following past investigations of survival and
locomotion outcomes after HF,16,35 we also created a composite outcome of death by 180 days or new total dependence in
locomotion at the last available assessment within 180 days
among all patients who were not totally dependent in locomotion at baseline. Among individuals for whom we had at
least 365 days of follow-up data (ie, those hospitalized between July 1, 2005, and December 31, 2008), we also examined mortality at 365 days and a composite outcome of death
by 365 days or new total dependence in locomotion at the latest available assessment within 365 days.

Statistical Analyses
Initial analyses used descriptive statistics and Kaplan-Meier
survival curves to characterize baseline features and outcomes among the full study sample and separately among men
and women. To assess within-residents changes in ADL function before and at 180 days after fracture, we examined the distribution of postfracture MDS self-performance scores within
each ADL domain among patients with the same level of baseline self-performance in that ADL. To account for deaths, these
analyses added a sixth outcome category, corresponding to
death within 180 days, to the 5-level MDS self-performance
scale.36 Patients who survived to 180 days after hospital admission but had no recorded postfracture MDS assessments
(362 patients [0.6% of the study sample]) were included in our
calculations for 180-day mortality but excluded from calculations related to 180-day functional outcomes; we took an analogous approach in analyzing 365-day outcomes.
We developed a multivariate Cox proportional hazards
model to measure the adjusted association of baseline patient factors and acute fracture management with postfracture survival, considering the survival time to be right censored for all patients who were alive as of December 31, 2009.
As a supplementary analysis, we also developed a regression
model to predict a binary outcome of death at 180 days; this
model used multivariate Poisson regression with robust variance estimates37-39 to measure the adjusted relative risks (RRs)
of mortality associated with specific patient factors and fracture management approaches. Finally, to measure the ad-
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justed association of baseline patient factors and acute fracture management with the composite outcome (death or new
total dependence in locomotion within 180 days), we estimated adjusted RRs using a multivariate Poisson regression
model with robust variance estimates.
We chose variables for inclusion in our regression models
based on clinical judgment and literature review. They included age, sex, race, Charlson comorbidity index score,30 fracture location, fracture management approach (internal fixation, hemiarthroplasty, total hip arthroplasty, or nonoperative
management), baseline cognitive performance, baseline locomotion self-performance, and the number out of 6 nonlocomotion ADLs with independent self-performance at baseline. While the survival model and the 180-day mortality model
each included all patients in our study sample, the model for
our composite outcome excluded those individuals who were
totally dependent in locomotion at baseline. As longitudinal
studies of health that exclude decedents may produce misleading results,36,40 we did not carry out regression analyses
restricted to patients who survived to 180 days after HF. Analyses used SAS 9.3 (SAS institute) statistical software. P < .05 was
considered statistically significant.

Results
Of 724 699 fee-for-service Medicare beneficiaries hospitalized with a HF over the study period, 60 111 (8.3%) were nursing home residents. Among these individuals, the median time
between the last prefracture MDS assessment and the index
admission was 39 days (interquartile range [IQR], 18-63 days).
Among patients who survived to 180 days after fracture, the
median number of days between the index admission and the
last available MDS assessment within 180 days was 128 days
(IQR, 103-166 days); within this group, the timing of the last
available MDS assessment ranged from 3 days to 180 days after admission.
Long-term nursing home patients with HF had a high degree of baseline comorbidity, ADL dependence, and cognitive impairment (Table 1). Within the overall sample, 26.6% had
a Charlson score of 4 or greater. At the last available MDS assessment prior to admission, 31.0% of the sample was independent in locomotion, but only 5.8% of the sample were independent in 6 of 6 nonlocomotion ADLs. At baseline, 9.3%
were cognitively intact. During the index hospitalization, 11.8%
of patients had no evidence of surgical HF treatment. Baseline characteristics differed between men and women in our
sample; while men more often had high degrees of comorbidity, women demonstrated a higher degree of dependence in
locomotion (see eTable 4 in the Supplement).
Of 60 111 patients in our full sample, 21 766 (36.2%) died
by 180 days after fracture (Figure 1 and Table 2). Median survival time after fracture was 377 days (IQR, 70-1002 days). Of
the 52 734 patients who were not totally dependent in locomotion at baseline, 28 225 (53.5%) either died or were newly
dependent in locomotion within 180 days; among patients who
survived to 180 days, new total dependence in locomotion occurred in 9438 of 33 947 (27.8%).
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Table 1. Baseline Characteristics and Acute Fracture Management
in 60111 Long-term US Nursing Home Residents Hospitalized
With Hip Fractures Between July 1, 2005, and June 30, 2009
Characteristic/Management

Figure 1. Survival at up to 365 Days Among 60111 US Long-term Care
Residents Hospitalized With Hip Fracture Between July 1, 2005,
and June 30, 2009

Residents, No. (%)

100

Sex
45 345 (75.4)

Male

14 766 (24.6)

Age, y

80

Survival Probability, %

Female

60

≤75

6662 (11.1)

76-80

8408 (14.0)

81-85

14 343 (23.9)

86-90

15 930 (26.5)

≥91

14 768 (24.6)

20

White

55 241 (91.9)

0

Black

3335 (5.5)

Other

1535 (2.6)

Female
Male

40

Race

Charlson score
0

4967 (8.3)

1

15 228 (25.3)

2

13 918 (23.2)

3

10 027 (16.7)

4

6551 (10.9)

≥5

9420 (15.7)

Baseline cognitive performance
Intact

5586 (9.3)

Borderline intact

5600 (9.3)

Mild impairment

10 120 (16.8)

Moderate impairment

25 296 (42.1)

Moderate-severe impairment

6340 (10.5)

Severe impairment

5889 (9.8)

Very severe impairment

1280 (2.1)

Baseline dependence in locomotion
Independent

18 638 (31.0)

Requires supervision

12 022 (20.0)

Requires limited assistance

12 497 (20.8)

Requires extensive assistance

9884 (16.4)

Total dependence

7070 (11.8)

No. out of 6 nonlocomotion ADLs
with functional independence
6

3503 (5.8)

4-5

5743 (9.6)

2-3

11 263 (18.7)

0-1

39 602 (65.9)

Fracture location
Femoral neck

28 380 (47.2)

Intertrochanteric

25 535 (42.5)

Subtrochanteric

2088 (3.5)

Multiple locations

4108 (6.8)

Acute fracture management
Hemiarthroplasty

18 760 (31.2)

Internal fixation

33 273 (55.4)

Total hip arthroplasty

1009 (1.7)

Nonoperative management

7069 (11.8)

Abbreviation: ADLs, activities of daily living (activities assessed include bed
mobility, transferring, dressing, personal hygiene, eating, and toileting).
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Male patients demonstrate a lower probability of survival than women at all
time points after fracture (P < .001 by log-rank test).

Among the 52 914 patients with at least 1 year of available
follow-up data, 24 883 (47.0%) died by 365 days. Among the
46 842 of these patients who were not totally dependent in locomotion at baseline, 28 114 (60.5%) either died or experienced new total dependence in locomotion within 365 days.
Among the 24 984 patients without total dependence in locomotion at baseline who had at least 365 days of follow-up data
and who survived 365 days after fracture, 6618 (26.5%) were
totally dependent in locomotion at 365 days.
Outcomes differed according to sex; compared with
women, death by 180 days and the 180-day composite outcome each occurred more frequently among men. Dependence in locomotion also occurred frequently among patients who died within 180 days of fracture; among the 16 153
decedents who had at least 1 postfracture ADL measurement,
90% were either totally dependent or required extensive assistance in locomotion at the last available assessment prior
to death.
Within individual residents, differences in the degree of independence in locomotion before and after fracture varied according to baseline locomotion status (Figure 1). Among patients
who were fully independent in locomotion at baseline, 21.0%
both survived to 180 days and were independent in locomotion
at their last available assessment within 180 days. Among patients
who required supervision in locomotion at baseline and among
those who required limited assistance for locomotion at baseline,
16.2% and 22.1%, respectively, both survived to 180 days and
attained or exceeded their prefracture level of independence
in locomotion by the last available assessment within 180
days (Figure 2). Marked within-residents changes in ADL selfperformance also occurred in transferring between surfaces, mobility in bed, dressing, personal hygiene, and toileting; smaller
changes occurred in ADL self-performance related to eating (see
eFigure in the Supplement).
In our proportional hazards model, male sex, increasing
age, white race, and high levels of comorbidity, cognitive impairment, locomotion dependence, and dependence in nonlocomotion ADLs were all significantly associated with de-
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Table 2. Study Outcomes
Residents, No./Total (%)
All

Female

Male

P Value,
Male vs Female

Death at 180 da

21 766/60 111 (36.2)

15 009/45 345 (33.1)

6757/14 766 (45.8)

<.001

Death or new total disability
in locomotion at 180 db

28 225/52 734 (53.5)

20 517/39 508 (51.9)

7708/13 226 (58.3)

<.001

Outcome

a

Sample includes all patients in starting cohort.

b

Sample includes all patients without total dependence in locomotion at baseline and all patients who either died by 180 days or who survived to 180 days and had
a valid Minimum Data Set assessment in the first 180 d following admission.

Figure 2. Survival to 180 Days and Within-Residents Changes in Locomotion Self-performance Among 59749 Nursing Home Residents
Hospitalized With Hip Fractures Between July 1, 2005, and June 30, 2009
Status at 180 days after fracture
Dead

Alive, requires limited assistance for locomotion

Alive, totally dependent in locomotion

Alive, requires supervision for locomotion

Alive, requires extensive assistance for locomotion

Alive, independent in locomotion

Totally dependent in locomotion at baseline
Required extensive assistance for locomotion at baseline
Required limited assistance for locomotion at baseline
Required supervision for locomotion at baseline
Independent in locomotion at baseline
0

20

40

60

80

100

Residents Within Category, %

For individuals within a given category of baseline locomotion
self-performance, the corresponding horizontal bar shows the fraction of
patients who died within 180 days, along with the distribution of postfracture
locomotion scores at the last available assessment within 180 days among
survivors. The bold vertical line intersecting each bar demarcates the fraction of

individuals within a baseline locomotion category who both survived to 180
days and regained or exceeded their baseline level of locomotion
self-performance at the latest available assessment within 180 days after
fracture.

creases in adjusted postfracture survival. Decreased survival
was also seen among patients with nonfemoral neck fractures, patients undergoing hemiarthroplasty or total hip arthroplasty vs internal fixation, and patients who received nonoperative management (Table 3). The factors most strongly
associated with decreased survival after fracture were age older
than 90 years (vs ≤75 years: hazard ratio [HR], 2.17; 95% CI, 2.092.26 [P < .001]), nonoperative fracture management (vs internal fixation: HR, 2.08; 95% CI, 2.01-2.15 [P < .001]), and a Charlson score of 5 or greater (vs 0: HR, 1.66; 95% CI, 1.58-1.73
[P < .001]). We obtained qualitatively similar results from a multivariate Poisson regression model that used the same set of
independent variables to predict a binary outcome of death at
180 days (see eTable 5 in the Supplement).
Most factors associated with decreased adjusted survival
were also associated with an increased adjusted risk of our composite outcome of death or new total dependence in locomotion within 180 days, although black patients were at slightly
elevated risk of experiencing this outcome compared with
white patients (RR, 1.05; 95% CI, 1.02-1.09 [P = .002]). In our
Poisson regression model, the factors most strongly associated with the composite adverse outcome were very severe cognitive impairment (vs intact cognition: RR, 1.66; 95% CI, 1.561.77 [P < .001]), nonoperative fracture management (vs internal

fixation: RR, 1.48; 95% CI, 1.45-1.51 [P < .001]), and age over
90 years (vs ≤75 years: RR, 1.42; 95% CI, 1.37-1.46 [P < .001]).

Discussion
In this study of 60 111 US long-term nursing home residents,
HFs were associated with substantial mortality and increases
in ADL dependence. By 180 days after fracture, more than 1 in
3 patients had died, including nearly 1 of every 2 men. Among
those individuals who had some degree of functional independence in locomotion at baseline, 1 of 2 had either died or
developed new total dependence in locomotion within 180
days after fracture.
Hip fractures were associated with profound increases in
dependence in multiple ADLs. Among patients who were fully
independent in locomotion at baseline or required supervision or limited assistance, approximately 1 in 5 survived to regain their prefracture level of independence in locomotion at
180 days after fracture; similar patterns were observed for other
ADLs, including transferring, mobility in bed, personal hygiene, and toileting.
Finally, we identified several risk factors for adverse outcomes after HF among nursing home residents. We classified
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Table 3. Predictors of Adverse Outcomes After Hip Fracture Among Nursing Home Residents

Predictor

Adjusted HR (95% CI)
for Survival After
Admission for Hip
Fracture (95% CI)a

P Value

Adjusted RR (95% CI)
for Death or New Total
Disability in Locomotion at
180 Days After Hip Fractureb

<.001

1.14 (1.12-1.16)

P Value

Sex
Female

1 [Reference]

Male

1.54 (1.51-1.58)

1 [Reference]
<.001

Age, y
≤75

1 [Reference]

76-80

1.20 (1.15-1.25)

<.001

1.08 (1.05-1.13)

1 [Reference]
<.001

81-85

1.40 (1.34-1.45)

<.001

1.18 (1.14-1.22)

<.001

86-90

1.65 (1.59-1.72)

<.001

1.26 (1.22-1.30)

<.001

≥91

2.17 (2.09-2.26)

<.001

1.42 (1.37-1.46)

<.001

Race
White

1 [Reference]

Black

0.77 (0.73-0.80)

<.001

1.05 (1.02-1.09)

1 [Reference]
.002

Other

0.74 (0.70-0.79)

<.001

0.94 (0.90-0.99)

.03

Charlson score
0

1 [Reference]

1

1.10 (1.05-1.15)

<.001

1.05 (1.02-1.09)

1 [Reference]
.005

2

1.22 (1.17-1.28)

<.001

1.06 (1.03-1.10)

<.001

3

1.35 (1.29-1.41)

<.001

1.11 (1.07-1.15)

<.001

4

1.44 (1.37-1.51)

<.001

1.13 (1.09-1.18)

<.001

≥5

1.66 (1.58-1.73)

<.001

1.20 (1.16-1.25)

<.001

Baseline cognitive performance
Intact

1 [Reference]

Borderline intact

1.01 (0.96-1.06)

.65

1.01 (0.97-1.05)

1 [Reference]
.63

Mild impairment

1.09 (1.05-1.14)

<.001

1.07 (1.04-1.11)

<.001

Moderate impairment

1.14 (1.10-1.19)

<.001

1.18 (1.14-1.22)

<.001

Moderate-severe impairment

1.22 (1.17-1.28)

<.001

1.34 (1.29-1.40)

<.001

Severe impairment

1.29 (1.23-1.35)

<.001

1.42 (1.37-1.47)

<.001

Very severe impairment

1.16 (1.07-1.25)

<.001

1.66 (1.56-1.77)

<.001

Baseline dependence
in locomotion
Independent

1 [Reference]

Requires supervision

1.02 (0.99-1.05)

.25

1.02 (1.00-1.05)

1 [Reference]
.051

Requires limited assistance

1.08 (1.04-1.11)

<.001

1.09 (1.06-1.11)

<.001
<.001

Requires extensive assistance

1.16 (1.12-1.20)

<.001

1.16 (1.13-1.19)

Total dependence

1.12 (1.08-1.17)

<.001

NA

No. out of 6 nonlocomotion
ADLs with functional
independence at baselinec
6

1 [Reference]

4-5

1.13 (1.07-1.19)

<.001

1.17 (1.11-1.23)

1 [Reference]
<.001

2-3

1.23 (1.17-1.30)

<.001

1.30 (1.24-1.37)

<.001

0-1

1.27 (1.20-1.33)

<.001

1.30 (1.24-1.37)

<.001

Abbreviations: ADLs, activities of
daily living; HR, hazard ratio; NA, not
applicable; RR, relative risk.
a

Sample includes all patients in
starting cohort (N = 60 111).

b

Sample includes all patients without
total dependence in locomotion at
baseline and all patients who either
died by 180 days or who survived to
180 days and had a valid Minimum
Data Set assessment in the first 180
days following admission
(n = 52 734).

c

Activities assessed include bed
mobility, transferring, dressing,
personal hygiene, eating, and
toileting.

Fracture location
Femoral neck

1 [Reference]

Intertrochanteric

1.10 (1.07-1.13)

Subtrochanteric
Multiple locations

1 [Reference]
<.001

1.10 (1.07-1.12)

<.001

1.09 (1.02-1.15)

.006

1.18 (1.12-1.23)

<.001

1.13 (1.08-1.18)

<.001

1.13 (1.10-1.17)

<.001

Acute fracture management

1278

Internal fixation

1 [Reference]

Total hip arthroplasty

1.15 (1.06-1.25)

<.001

1.10 (1.03-1.18)

1 [Reference]
.003

Hemiarthroplasty

1.10 (1.07-1.14)

<.001

1.12 (1.10-1.15)

<.001

Nonoperative management

2.08 (2.01-2.15)

<.001

1.48 (1.45-1.51)

<.001
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11.8% of patients in our sample as having received nonoperative management, a rate approximately twice that seen in the
overall Medicare population.41 Within our cohort, nonoperative care was associated with marked decreases in survival
after HF and a substantially greater adjusted risk of death or
new total dependence in locomotion within 180 days compared with internal fixation. While this finding may be due in
part to the sickest patients electing to undergo nonoperative
management, it would also be consistent with a substantial
negative effect of nonoperative care on outcomes. Beyond nonoperative fracture management, male sex, increasing age, white
race, high levels of comorbidity, advanced cognitive impairment, nonfemoral neck fracture location, and increasing baseline ADL dependence were all associated with decreased survival after HF. Most of these same factors were also associated
with a significantly elevated risk of the composite outcome of
death or new total dependence in locomotion within 180 days,
although we did observe black patients to be at a slightly higher
risk of experiencing the composite outcome compared with
white patients. Overall, the presence of very severe cognitive
impairment at baseline was associated with the greatest increase in the risk of this outcome.
Poor outcomes among long-term nursing home residents
with HF have previously been noted in small cohort
studies12,16,17 and single-center investigations.18-20 For example, in a study of 195 long-term care residents from a single
US institution who experienced a HF between 1999 and 2006,
Berry and colleagues18 noted an overall mortality rate of 40%
at 1 year. Similarly, among 60 ambulatory nursing home patients with HF in Canada in 2008 and 2009, Beaupre and
colleagues16 noted a 45% mortality rate and a combined rate
of death or new inability to ambulate of 63% at 1 year. Among
38 patients with end-stage dementia and HF, the majority of
whom were long-term nursing home residents, Morrison and
Siu20 reported a 6-month mortality of 55%.
Our study confirms and extends these prior findings. To our
knowledge, ours is the largest and most comprehensive study
to date of outcomes following HF among nursing home residents. By taking advantage of a large, national data set, this study
provides a reliable and highly generalizable description of the
experiences of nursing home residents who experience HFs. Furthermore, it provides important insight into the heterogeneous nature of HF as a clinical syndrome. While past investigators have identified selected risk factors for adverse outcomes
after HF in general,10,11 our findings offer new evidence regarding specific baseline risk factors for adverse outcomes at 180 days
among nursing home residents who experience HFs.
Our study has limitations. Because MedPAR files do not
contain records on HMO patients, we were unable to identify
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HMO patients with HF. While our study data set contained detailed clinical information on the patients in our sample, we
cannot rule out unobserved differences in severity of illness
that may have partially explained differences in outcomes we
observe across groups of patients, such as those receiving operative vs nonoperative care. Because we did not examine the
effect of postacute care services on outcomes, we cannot comment here on the impact of variations in the quality of postfracture nursing home care on survival or functional recovery. Furthermore, because additional recovery may have
occurred beyond the date of each patient’s latest available MDS
assessment, our analyses may underestimate the true extent
of functional recovery at 180 days. Finally, as our composite
outcome incorporates information on both survival and postfracture locomotion, it should not be interpreted as a measure of the relative likelihood of new dependence in locomotion after fracture per se; rather, it is a more general indicator
of the likelihood of an adverse health outcome, defined here
as death or the development of new total dependence within
180 days after fracture.

Conclusions
Despite these limitations, our findings have important
implications for clinical practice and health care delivery.
Residents of long-term nursing facilities represent a
uniquely vulnerable subset of all patients with HF, and
approaches to clinical care for these individuals should consider the high probability of death and functional disability
after fracture in this group. In particular, the extreme rates
of mortality and functional disability documented herein
suggest that counseling regarding prognosis for survival and
recovery, explicit discussions of goals of care, and aggressive efforts to control pain and other distressing symptoms
represent essential components of management for nursing
home residents with HF. At the same time, our observation
of substantially worse risk-adjusted outcomes among
patients receiving nonoperative management suggests that
indicated operative fracture treatment may be reasonable
even in the presence of advanced comorbidity, cognitive
impairment, or baseline functional dependence if it is consistent with patients’ overall goals of care. More generally,
our findings emphasize the importance of continued efforts
to prevent HFs among nursing home residents, and they
stress the need for further research on the potential for
quality improvement initiatives, potentially including specialized inpatient geriatric fracture programs, to improve
outcomes among nursing home residents who sustain HFs.
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